{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:16:37Z","timestamp":1783304197270,"version":"3.54.6"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"DOI":"10.1007\/s12033-026-01595-w","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T16:40:18Z","timestamp":1783269618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applications of Recombinant DNA Technology in Medicine: A Comprehensive Review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0583-4619","authenticated-orcid":false,"given":"Krishan","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"key":"1595_CR1","volume-title":"Molecular biotechnology: Principles and applications of recombinant DNA","author":"BR Glick","year":"2022","unstructured":"Glick, B. R., & Patten, C. L. (2022). Molecular biotechnology: Principles and applications of recombinant DNA. Wiley."},{"key":"1595_CR2","doi-asserted-by":"publisher","DOI":"10.1142\/9781783263851_0011","author":"A Soutar","year":"2014","unstructured":"Soutar, A. (2014). Herbert Boyer and Stanley Cohen: Recombinant DNA. In Pioneers of Medicine Without a Nobel Prize. https:\/\/doi.org\/10.1142\/9781783263851_0011","journal-title":"In Pioneers of Medicine Without a Nobel Prize"},{"key":"1595_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-36130-3_1","volume-title":"Biotechnology business-concept to delivery","author":"H Kumar","year":"2020","unstructured":"Kumar, H. (2020). Biotechnology: Discoveries and their applications in societal welfare. Biotechnology business-concept to delivery (pp. 3\u201344). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-36130-3_1"},{"key":"1595_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/B978-0-443-21980-1.00012-7","volume-title":"Genome analysis","author":"M Sengar","year":"2026","unstructured":"Sengar, M., Ahirwar, V., Rathore, M., Gupta, A., Sachan, A., Kashyap, N., & Tiwari, A. (2026). Gene cloning and protein expression systems. Genome analysis (pp. 147\u2013182). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-443-21980-1.00012-7"},{"key":"1595_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.virusres.2013.12.007","volume":"186","author":"N Boonham","year":"2014","unstructured":"Boonham, N., Kreuze, J., Winter, S., van der Vlugt, R., Bergervoet, J., Tomlinson, J., & Mumford, R. (2014). Methods in virus diagnostics: From ELISA to next generation sequencing. Virus Research, 186, 20\u201331. https:\/\/doi.org\/10.1016\/j.virusres.2013.12.007","journal-title":"Virus Research"},{"key":"1595_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-96-4959-4_1","volume-title":"Biotechnology and cancer therapeutics","author":"M Nigam","year":"2025","unstructured":"Nigam, M., Singh, N., Dimri, D. B., & Mishra, A. P. (2025). Biotechnology in medicine: Fundamentals. Biotechnology and cancer therapeutics (pp. 1\u201324). Springer Nature Singapore. https:\/\/doi.org\/10.1007\/978-981-96-4959-4_1"},{"issue":"6","key":"1595_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/19420862.2017.1343709","volume":"9","author":"S Mahler","year":"2017","unstructured":"Mahler, S. (2017). Safety of biologics therapy: Monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines, botulinum toxins. In MAbs, 9(6), 885\u2013888. https:\/\/doi.org\/10.1080\/19420862.2017.1343709","journal-title":"In MAbs"},{"key":"1595_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/B978-0-443-22300-6.00044-9","volume-title":"Molecular medicine and biomedical research in the era of precision medicine","author":"AV Kumar","year":"2025","unstructured":"Kumar, A. V., Garg, V. K., & Buttar, H. S. (2025). Harnessing CRISPR\/Cas systems for tailored therapeutic interventions in molecular medicine: Advancements in precision medicine and enhanced patient care. Molecular medicine and biomedical research in the era of precision medicine (pp. 397\u2013425). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-443-22300-6.00044-9"},{"key":"1595_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/B978-0-443-22264-1.00013-X","volume-title":"Medicinal biotechnology","author":"S Kumar","year":"2025","unstructured":"Kumar, S., Singh, R., & Katiyar, H. (2025). Production of therapeutic vaccines, antibiotics, and hormones. Medicinal biotechnology (pp. 251\u2013272). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-443-22264-1.00013-X"},{"issue":"1","key":"1595_CR10","doi-asserted-by":"publisher","first-page":"2405954","DOI":"10.1155\/2016\/2405954","volume":"2016","author":"S Khan","year":"2016","unstructured":"Khan, S., Ullah, M. W., Siddique, R., Nabi, G., Manan, S., Yousaf, M., & Hou, H. (2016). Role of recombinant DNA technology to improve life. International journal of genomics, 2016(1), 2405954. https:\/\/doi.org\/10.1155\/2016\/2405954","journal-title":"International journal of genomics"},{"issue":"1","key":"1595_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/089106098435421","volume":"10","author":"MW Ho","year":"1998","unstructured":"Ho, M. W., Traavik, T., Olsvik, O., Tappeser, B., Howard, C. V., von Weizsacker, C., & McGavin, G. C. (1998). Gene technology and gene ecology of infectious diseases. Microbial Ecology in Health and Disease, 10(1), 33\u201359. https:\/\/doi.org\/10.1080\/089106098435421","journal-title":"Microbial Ecology in Health and Disease"},{"key":"1595_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-981-97-3169-5_13","volume-title":"Advances in genomics: Methods and applications","author":"G Abdi","year":"2024","unstructured":"Abdi, G., Patil, N., Mishra, P., Tariq, M., Dhariwal, R., Parveen, S., Dave, K., Jain, M., Tarighat, M. A., & Mudgal, G. (2024). Genomic precision: Unveiling the transformative role of genome editing in advancing genomics research and applications. Advances in genomics: Methods and applications (pp. 265\u2013306). Springer Nature Singapore. https:\/\/doi.org\/10.1007\/978-981-97-3169-5_13"},{"key":"1595_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-08-100623-8.00003-7","volume-title":"Biopharmaceutical processing","author":"G Jagschies","year":"2018","unstructured":"Jagschies, G. (2018). Selected biotherapeutics overview. Biopharmaceutical processing (pp. 59\u201372). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-08-100623-8.00003-7"},{"issue":"6","key":"1595_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00705-022-05432-8","volume":"167","author":"M bin Umair","year":"2022","unstructured":"bin Umair, M., Akusa, F. N., Kashif, H., Butt, F., Azhar, M., Munir, I., Ahmed, M., Khalil, W., Sharyar, H., Rafique, S., & Shahid, M. (2022). Viruses as tools in gene therapy, vaccine development, and cancer treatment. Archives of Virology, 167(6), 1387\u20131404. https:\/\/doi.org\/10.1007\/s00705-022-05432-8","journal-title":"Archives of Virology"},{"issue":"7","key":"1595_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0141-0229(03)00205-9","volume":"33","author":"KJ Prather","year":"2003","unstructured":"Prather, K. J., Sagar, S., Murphy, J., & Chartrain, M. (2003). Industrial scale production of plasmid DNA for vaccine and gene therapy: Plasmid design, production, and purification. Enzyme and Microbial Technology, 33(7), 865\u2013883. https:\/\/doi.org\/10.1016\/S0141-0229(03)00205-9","journal-title":"Enzyme and Microbial Technology"},{"key":"1595_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-0-12-816061-9.00003-5","volume-title":"Principles and applications of molecular diagnostics","author":"SA Thatcher","year":"2018","unstructured":"Thatcher, S. A. (2018). Nucleic acid isolation. Principles and applications of molecular diagnostics (pp. 35\u201346). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-12-816061-9.00003-5"},{"key":"1595_CR17","first-page":"83","volume-title":"Integrated microfabricated biodevices","author":"R Ramanujam","year":"2002","unstructured":"Ramanujam, R., Sacks, W., & Kang, J. (2002). Basic sample preparation: DNA separation and purification. Integrated microfabricated biodevices (pp. 83\u201398). CRC Press."},{"key":"1595_CR18","doi-asserted-by":"crossref","unstructured":"Neumaier, M., Braun, A., Wagener, C., & International Federation of Clinical Chemistry Scientific Division Committee on Molecular. (1998). Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics.\u00a0Clinical chemistry, 44(1):12-26","DOI":"10.1093\/clinchem\/44.1.12"},{"issue":"2","key":"1595_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s002400050093","volume":"27","author":"DH Schamhart","year":"1999","unstructured":"Schamhart, D. H., & Westerhof, A. C. (1999). Strategies for gene cloning. Urological Research, 27(2), 83\u201396. https:\/\/doi.org\/10.1007\/s002400050093","journal-title":"Urological Research"},{"key":"1595_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-561-9_6","author":"O Tolmachov","year":"2009","unstructured":"Tolmachov, O. (2009). Designing plasmid vectors. Gene Therapy of Cancer Methods and Protocols. https:\/\/doi.org\/10.1007\/978-1-59745-561-9_6","journal-title":"Gene Therapy of Cancer Methods and Protocols"},{"key":"1595_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.57238\/tpb.2024.153196.1020","volume":"51","author":"BA Morgan","year":"1996","unstructured":"Morgan, B. A., & Fekete, D. M. (1996). Manipulating gene expression with replication\u2013competent retroviruses. Methods in cell biology, 51, 185\u2013218. https:\/\/doi.org\/10.57238\/tpb.2024.153196.1020","journal-title":"Methods in cell biology"},{"issue":"1-2","key":"1595_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0378-1119(98)00396-5","volume":"219","author":"DO Chaffin","year":"1998","unstructured":"Chaffin, D. O., & Rubens, C. E. (1998). Blue\/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene, 219(1\u20132), 91\u201399. https:\/\/doi.org\/10.1016\/s0378-1119(98)00396-5","journal-title":"Gene"},{"issue":"1","key":"1595_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/02648725.2014.921501","volume":"30","author":"K Sharma","year":"2014","unstructured":"Sharma, K., Mishra, A. K., Mehraj, V., & Duraisamy, G. S. (2014). Advances and applications of molecular cloning in clinical microbiology. Biotechnology and Genetic Engineering Reviews, 30(1), 65\u201378. https:\/\/doi.org\/10.1080\/02648725.2014.921501","journal-title":"Biotechnology and Genetic Engineering Reviews"},{"issue":"1","key":"1595_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/21655979.2019.1682108","volume":"10","author":"S Sarsaiya","year":"2019","unstructured":"Sarsaiya, S., Shi, J., & Chen, J. (2019). Bioengineering tools for the production of pharmaceuticals: Current perspective and future outlook. Bioengineered, 10(1), 469\u2013492. https:\/\/doi.org\/10.1080\/21655979.2019.1682108","journal-title":"Bioengineered"},{"issue":"2","key":"1595_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcp.21423","volume":"216","author":"C Lico","year":"2008","unstructured":"Lico, C., Chen, Q., & Santi, L. (2008). Viral vectors for production of recombinant proteins in plants. Journal of Cellular Physiology, 216(2), 366\u2013377. https:\/\/doi.org\/10.1002\/jcp.21423","journal-title":"Journal of Cellular Physiology"},{"issue":"41","key":"1595_CR26","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1016\/j.vaccine.2012.02.061","volume":"30","author":"R Ismail","year":"2012","unstructured":"Ismail, R., Allaudin, Z. N., & Lila, M. A. M. (2012). Scaling-up recombinant plasmid DNA for clinical trial: Current concern, solution and status. Vaccine, 30(41), 5914\u20135920. https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.061","journal-title":"Vaccine"},{"issue":"5","key":"1595_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.biotechadv.2011.09.013","volume":"30","author":"R Chen","year":"2012","unstructured":"Chen, R. (2012). Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnology Advances, 30(5), 1102\u20131107. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.09.013","journal-title":"Biotechnology Advances"},{"issue":"4","key":"1595_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li, C., & Samulski, R. J. (2020). Engineering adeno-associated virus vectors for gene therapy. Nature Reviews Genetics, 21(4), 255\u2013272. https:\/\/doi.org\/10.1038\/s41576-019-0205-4","journal-title":"Nature Reviews Genetics"},{"issue":"1","key":"1595_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12967-016-1047-x","volume":"14","author":"JE Vargas","year":"2016","unstructured":"Vargas, J. E., Chicaybam, L., Stein, R. T., Tanuri, A., Delgado-Ca\u00f1edo, A., & Bonamino, M. H. (2016). Retroviral vectors and transposons for stable gene therapy: Advances, current challenges and perspectives. Journal of Translational Medicine, 14(1), 288. https:\/\/doi.org\/10.1186\/s12967-016-1047-x","journal-title":"Journal of Translational Medicine"},{"key":"1595_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9781394271566.ch4","author":"VP Chavda","year":"2025","unstructured":"Chavda, V. P., Balar, P. C., Vaghela, D. A., Teli, D., Chaudhari, A., & Alom, S. (2025). Replication-Competent Viral Vectors for Vaccine Delivery. Viral Vectors for Vaccine Delivery. https:\/\/doi.org\/10.1002\/9781394271566.ch4","journal-title":"Viral Vectors for Vaccine Delivery"},{"key":"1595_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-030-96851-9_6","volume-title":"A complete guide to gene cloning: From basic to advanced","author":"S Rajpathak","year":"2022","unstructured":"Rajpathak, S., Vyawahare, R., Patil, N., & Sivaram, A. (2022). Fundamental techniques of recombinant DNA transfer. A complete guide to gene cloning: From basic to advanced (pp. 79\u201395). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-96851-9_6"},{"issue":"4","key":"1595_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/07352689.2013.870422","volume":"33","author":"D Breyer","year":"2014","unstructured":"Breyer, D., Kopertekh, L., & Reheul, D. (2014). Alternatives to antibiotic resistance marker genes for in vitro selection of genetically modified plants\u2013Scientific developments, current use, operational access and biosafety considerations. Critical Reviews in Plant Sciences, 33(4), 286\u2013330. https:\/\/doi.org\/10.1080\/07352689.2013.870422","journal-title":"Critical Reviews in Plant Sciences"},{"key":"1595_CR33","doi-asserted-by":"publisher","DOI":"10.5772\/22140","author":"S Padmanabhan","year":"2011","unstructured":"Padmanabhan, S., Banerjee, S., & Mandi, N. (2011). Screening of bacterial recombinants: Strategies and preventing false positives. Molecular Cloning-Selected Applications in Medicine and Biology. https:\/\/doi.org\/10.5772\/22140","journal-title":"Molecular Cloning-Selected Applications in Medicine and Biology"},{"issue":"2","key":"1595_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4161\/bbug.1.2.10484","volume":"1","author":"JL Adrio","year":"2010","unstructured":"Adrio, J. L., & Demain, A. L. (2010). Recombinant organisms for production of industrial products. Bioengineered Bugs, 1(2), 116\u2013131. https:\/\/doi.org\/10.4161\/bbug.1.2.10484","journal-title":"Bioengineered Bugs"},{"issue":"9","key":"1595_CR35","first-page":"1121","volume":"80","author":"M Rai","year":"2001","unstructured":"Rai, M., & Padh, H. (2001). Expression systems for production of heterologous proteins. Current science, 80(9), 1121\u20131128.","journal-title":"Current science"},{"issue":"1","key":"1595_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-025-02646-8","volume":"24","author":"A De Marco","year":"2025","unstructured":"De Marco, A. (2025). Recent advances in recombinant production of soluble proteins in E. coli. Microbial Cell Factories, 24(1), Article 21. https:\/\/doi.org\/10.1186\/s12934-025-02646-8","journal-title":"Microbial Cell Factories"},{"issue":"3","key":"1595_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1586\/14789450.3.3.345","volume":"3","author":"SA Brooks","year":"2006","unstructured":"Brooks, S. A. (2006). Protein glycosylation in diverse cell systems: Implications for modification and analysis of recombinant proteins. Expert Review of Proteomics, 3(3), 345\u2013359. https:\/\/doi.org\/10.1586\/14789450.3.3.345","journal-title":"Expert Review of Proteomics"},{"key":"1595_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bej.2018.07.013","volume":"138","author":"X Jin","year":"2018","unstructured":"Jin, X., & Hong, S. H. (2018). Cell-free protein synthesis for producing \u2018difficult-to-express\u2019 proteins. Biochemical Engineering Journal, 138, 156\u2013164. https:\/\/doi.org\/10.1016\/j.bej.2018.07.013","journal-title":"Biochemical Engineering Journal"},{"issue":"3","key":"1595_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.sbi.2013.03.008","volume":"23","author":"R Assenberg","year":"2013","unstructured":"Assenberg, R., Wan, P. T., Geisse, S., & Mayr, L. M. (2013). Advances in recombinant protein expression for use in pharmaceutical research. Current Opinion in Structural Biology, 23(3), 393\u2013402. https:\/\/doi.org\/10.1016\/j.sbi.2013.03.008","journal-title":"Current Opinion in Structural Biology"},{"issue":"1","key":"1595_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1751-7915.13318","volume":"12","author":"LC Nora","year":"2019","unstructured":"Nora, L. C., Westmann, C. A., Martins-Santana, L., Alves, L. D. F., Monteiro, L. M. O., Guazzaroni, M. E., & Silva-Rocha, R. (2019). The art of vector engineering: Towards the construction of next-generation genetic tools. Microbial Biotechnology, 12(1), 125\u2013147. https:\/\/doi.org\/10.1111\/1751-7915.13318","journal-title":"Microbial Biotechnology"},{"key":"1595_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-981-97-4235-6_12","volume-title":"Microbial products for health and nutrition","author":"S Parasuraman","year":"2024","unstructured":"Parasuraman, S., Kumar, L. N. D., Thanapakiam, G., Sayem, A. S. M., Chuah, J. J., & Venkateskumar, K. (2024). Biopharmaceutical production by recombinant DNA technology: Future perspectives. Microbial products for health and nutrition (pp. 285\u2013303). Springer Nature Singapore. https:\/\/doi.org\/10.1007\/978-981-97-4235-6_12"},{"issue":"9","key":"1595_CR42","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics17091183","volume":"17","author":"TG Bas","year":"2025","unstructured":"Bas, T. G. (2025). Formulation of recombinant therapeutic proteins: Technological innovation, regulations, and evolution towards buffer-free formulations. Pharmaceutics, 17(9), 1183. https:\/\/doi.org\/10.3390\/pharmaceutics17091183","journal-title":"Pharmaceutics"},{"key":"1595_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-981-10-0875-7_4","volume-title":"Basic and applied aspects of biotechnology","author":"V Gupta","year":"2016","unstructured":"Gupta, V., Sengupta, M., Prakash, J., & Tripathy, B. C. (2016). Production of recombinant pharmaceutical proteins. Basic and applied aspects of biotechnology (pp. 77\u2013101). Springer Singapore. https:\/\/doi.org\/10.1007\/978-981-10-0875-7_4"},{"issue":"9205","key":"1595_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s0140-6736(00)01034-5","volume":"355","author":"FC Breedveld","year":"2000","unstructured":"Breedveld, F. C. (2000). Therapeutic monoclonal antibodies. Lancet, 355(9205), 735\u2013740. https:\/\/doi.org\/10.1016\/s0140-6736(00)01034-5","journal-title":"Lancet"},{"issue":"9","key":"1595_CR45","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.15419\/bmrat.v8i9.692","volume":"8","author":"J Alyas","year":"2021","unstructured":"Alyas, J., Rafiq, A., Amir, H., Khan, S. U., Sultana, T., Ali, A., Hameed, A., Ahmad, I., Kazmi, A., Sajid, T., & Ahmad, A. (2021). Human insulin: History, recent advances, and expression systems for mass production. Biomedical Research and Therapy, 8(9), 4540\u20134561. https:\/\/doi.org\/10.15419\/bmrat.v8i9.692","journal-title":"Biomedical Research and Therapy"},{"issue":"6","key":"1595_CR46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/bp00018a001","volume":"8","author":"MR Ladisch","year":"1992","unstructured":"Ladisch, M. R., & Kohlmann, K. L. (1992). Recombinant human insulin. Biotechnology progress, 8(6), 469\u2013478.","journal-title":"Biotechnology progress"},{"issue":"8","key":"1595_CR47","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/s2213-8587(15)00097-2","volume":"3","author":"A Cahn","year":"2015","unstructured":"Cahn, A., Miccoli, R., Dardano, A., & Del Prato, S. (2015). New forms of insulin and insulin therapies for the treatment of type 2 diabetes. The Lancet Diabetes & Endocrinology, 3(8), 638\u2013652. https:\/\/doi.org\/10.1016\/s2213-8587(15)00097-2","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"2","key":"1595_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1210\/jc.2007-1723","volume":"93","author":"K Bolar","year":"2008","unstructured":"Bolar, K., Hoffman, A. R., Maneatis, T., & Lippe, B. (2008). Long-term safety of recombinant human growth hormone in turner syndrome. The Journal of Clinical Endocrinology & Metabolism, 93(2), 344\u2013351. https:\/\/doi.org\/10.1210\/jc.2007-1723","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"1595_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.21037\/tp-2024-576","volume":"14","author":"Q Zhao","year":"2025","unstructured":"Zhao, Q., Li, R., Shao, Q., Zhang, M., & Ban, B. (2025). Recombinant growth hormone improves growth and adult height: A comparison between treated and untreated patients with idiopathic growth hormone deficiency. Translational Pediatrics, 14(3), 442. https:\/\/doi.org\/10.21037\/tp-2024-576","journal-title":"Translational Pediatrics"},{"issue":"1","key":"1595_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2008.11.002","volume":"122","author":"CA Bonjardim","year":"2009","unstructured":"Bonjardim, C. A., Ferreira, P. C., & Kroon, E. G. (2009). Interferons: Signaling, antiviral and viral evasion. Immunology Letters, 122(1), 1\u201311. https:\/\/doi.org\/10.1016\/j.imlet.2008.11.002","journal-title":"Immunology Letters"},{"issue":"1","key":"1595_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/biot.200700214","volume":"3","author":"T Dingermann","year":"2008","unstructured":"Dingermann, T. (2008). Recombinant therapeutic proteins: Production platforms and challenges. Biotechnology Journal: Healthcare Nutrition Technology, 3(1), 90\u201397. https:\/\/doi.org\/10.1002\/biot.200700214","journal-title":"Biotechnology Journal: Healthcare Nutrition Technology"},{"issue":"2","key":"1595_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cytogfr.2014.12.006","volume":"26","author":"G Antonelli","year":"2015","unstructured":"Antonelli, G., Scagnolari, C., Moschella, F., & Proietti, E. (2015). Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use. Cytokine & Growth Factor Reviews, 26(2), 121\u2013131. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.12.006","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"4","key":"1595_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/vaccines9040328","volume":"9","author":"LS Castro","year":"2021","unstructured":"Castro, L. S., Lobo, G. S., Pereira, P., Freire, M. G., Neves, M. C., & Pedro, A. Q. (2021). Interferon-based biopharmaceuticals: Overview on the production, purification, and formulation. Vaccines, 9(4), 328. https:\/\/doi.org\/10.3390\/vaccines9040328","journal-title":"Vaccines"},{"issue":"5","key":"1595_CR54","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1007\/s10528-024-10911-5","volume":"63","author":"MZ Saleem","year":"2025","unstructured":"Saleem, M. Z., Jahangir, G. Z., Saleem, A., Zulfiqar, A., Khan, K. A., Ercisli, S., Ali, B., Saleem, M. H., & Saleem, A. (2025). Production technologies for recombinant antibodies: Insights into eukaryotic, prokaryotic, and transgenic expression systems. Biochemical Genetics, 63(5), 3928\u20133967. https:\/\/doi.org\/10.1007\/s10528-024-10911-5","journal-title":"Biochemical Genetics"},{"issue":"2","key":"1595_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.57238\/tpb.2024.153196.1019","volume":"2","author":"SE Udeabor","year":"2024","unstructured":"Udeabor, S. E. (2024). Monoclonal antibodies in modern medicine: Their therapeutic potential and future directions. Trends in Pharmaceutical Biotechnology., 2(2), 12\u201320.","journal-title":"Trends in Pharmaceutical Biotechnology."},{"issue":"5013","key":"1595_CR56","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1126\/science.2047874","volume":"252","author":"TA Waldmann","year":"1991","unstructured":"Waldmann, T. A. (1991). Monoclonal antibodies in diagnosis and therapy. Science, 252(5013), 1657\u20131662. https:\/\/doi.org\/10.1126\/science.2047874","journal-title":"Science"},{"issue":"3","key":"1595_CR57","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2174\/0929867328666210526144654","volume":"29","author":"M Marchetti","year":"2022","unstructured":"Marchetti, M., Faggiano, S., & Mozzarelli, A. (2022). Enzyme replacement therapy for genetic disorders associated with enzyme deficiency. Current Medicinal Chemistry, 29(3), 489\u2013525. https:\/\/doi.org\/10.2174\/0929867328666210526144654","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"1595_CR58","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2165\/00003495-200262050-00002","volume":"62","author":"R Schiffmann","year":"2002","unstructured":"Schiffmann, R., & Brady, R. O. (2002). New prospects for the treatment of lysosomal storage diseases. Drugs, 62(5), 733\u2013742. https:\/\/doi.org\/10.2165\/00003495-200262050-00002","journal-title":"Drugs"},{"issue":"2","key":"1595_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.71465\/fbg72","volume":"1","author":"A Khan","year":"2024","unstructured":"Khan, A. (2024). Biotechnological approaches to rare genetic disorders: Innovations and challenges. Frontiers in Biotechnology and Genetics, 1(2), 88\u2013106.","journal-title":"Frontiers in Biotechnology and Genetics"},{"key":"1595_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.medntd.2025.100375","volume":"27","author":"P Kandhare","year":"2025","unstructured":"Kandhare, P., Kurlekar, M., Deshpande, T., & Pawar, A. (2025). Artificial intelligence in pharmaceutical sciences: A comprehensive review. Medicine in Novel Technology and Devices, 27, Article 100375. https:\/\/doi.org\/10.1016\/j.medntd.2025.100375","journal-title":"Medicine in Novel Technology and Devices"},{"issue":"6","key":"1595_CR61","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s44222-025-00301-w","volume":"3","author":"PJ Gardner","year":"2025","unstructured":"Gardner, P. J., Loynachan, C., Tsekoa, T. L., Keir, L., Yabannavar, V., & Sparrow, E. (2025). Manufacturing innovation is essential for monoclonal antibody affordability and access. Nature Reviews Bioengineering, 3(6), 438\u2013440. https:\/\/doi.org\/10.1038\/s44222-025-00301-w","journal-title":"Nature Reviews Bioengineering"},{"key":"1595_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123407","volume":"233","author":"A Beygmoradi","year":"2023","unstructured":"Beygmoradi, A., Homaei, A., Hemmati, R., & Fernandes, P. (2023). Recombinant protein expression: Challenges in production and folding related matters. International Journal of Biological Macromolecules, 233, Article 123407. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123407","journal-title":"International Journal of Biological Macromolecules"},{"issue":"12","key":"1595_CR63","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41573-024-01051-x","volume":"23","author":"PJ Carter","year":"2024","unstructured":"Carter, P. J., & Quarmby, V. (2024). Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics. Nature Reviews Drug Discovery, 23(12), 898\u2013913. https:\/\/doi.org\/10.1038\/s41573-024-01051-x","journal-title":"Nature Reviews Drug Discovery"},{"key":"1595_CR64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-3-030-42319-3_26","volume-title":"Functional foods and nutraceuticals: Bioactive components, formulations and innovations","author":"M Akram","year":"2020","unstructured":"Akram, M., Jabeen, F., Daniyal, M., Zainab, R., ul Haq, U., Adetunji, C. O., Egbuna, C., Ephraim-Emmanuel, B. C., Patrick-Iwuanyanwu, K. C., & Ogbo, A. B. (2020). Genetic engineering of novel products of health significance: Recombinant DNA technology. Functional foods and nutraceuticals: Bioactive components, formulations and innovations (pp. 595\u2013611). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-42319-3_26"},{"key":"1595_CR65","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/0264-410X(90)90221-7","volume":"8","author":"J Stephenne","year":"1990","unstructured":"Stephenne, J. (1990). Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine, 8, S69\u2013S73. https:\/\/doi.org\/10.1016\/0264-410X(90)90221-7","journal-title":"Vaccine"},{"key":"1595_CR66","doi-asserted-by":"publisher","first-page":"1697177","DOI":"10.3389\/fimmu.2025.1697177","volume":"16","author":"A Ramos Vega","year":"2025","unstructured":"Ramos Vega, A., Monreal-Escalante, E., Ba\u00f1uelos-Hern\u00e1ndez, B., Angulo, M., Trujillo, E., & Angulo, C. (2025). Yeast vaccine production platform for human and animal infectious diseases. Frontiers in Immunology, 16, 1697177. https:\/\/doi.org\/10.3389\/fimmu.2025.1697177","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"1595_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","volume":"6","author":"SA Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a, S. A., Lorincz, R., Boucher, P., & Curiel, D. T. (2021). Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines, 6(1), 97. https:\/\/doi.org\/10.1038\/s41541-021-00356-x","journal-title":"NPJ Vaccines"},{"issue":"8","key":"1595_CR68","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4103\/apjtm.apjtm_854_23","volume":"17","author":"V Kumar","year":"2024","unstructured":"Kumar, V., Verma, A., Singh, R., Garg, P., Sharma, S. K., Singh, H. N., Mishra, S. K., & Kumar, S. (2024). Recombinant vaccines: Current updates and future prospects. Asian Pacific Journal of Tropical Medicine, 17(8), 338\u2013350. https:\/\/doi.org\/10.4103\/apjtm.apjtm_854_23","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"issue":"2","key":"1595_CR69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/ba20000034","volume":"32","author":"M Hansson","year":"2000","unstructured":"Hansson, M., Nygren, P. A. K., & Sta\u02da hl, S. (2000). Design and production of recombinant subunit vaccines. Biotechnology and Applied Biochemistry, 32(2), 95\u2013107. https:\/\/doi.org\/10.1042\/ba20000034","journal-title":"Biotechnology and Applied Biochemistry"},{"key":"1595_CR70","first-page":"263","volume":"13","author":"RL Garnick","year":"1991","unstructured":"Garnick, R. L., Ross, M. J., & Baffi, R. A. (1991). Recombinant DNA manufacture. Drug biotechnology regulation: Scientific basis and practices, 13, 263.","journal-title":"Drug biotechnology regulation: Scientific basis and practices"},{"key":"1595_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-18564-9.00030-8","author":"T Andey","year":"2024","unstructured":"Andey, T., Soni, S., & Modi, S. (2024). Conventional vaccination methods: Inactivated and live attenuated vaccines. Advanced Vaccination Technologies for Infectious and Chronic Diseases. https:\/\/doi.org\/10.1016\/B978-0-443-18564-9.00030-8","journal-title":"Advanced Vaccination Technologies for Infectious and Chronic Diseases"},{"issue":"7","key":"1595_CR72","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jama.2009.1201","volume":"302","author":"BA Slade","year":"2009","unstructured":"Slade, B. A., Leidel, L., Vellozzi, C., Woo, E. J., Hua, W., Sutherland, A., Izurieta, H. S., Ball, R., Miller, N., Braun, M. M., & Markowitz, L. E. (2009). Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA, 302(7), 750\u2013757. https:\/\/doi.org\/10.1001\/jama.2009.1201","journal-title":"JAMA"},{"issue":"1","key":"1595_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-065x.2010.00980.x","volume":"239","author":"MA Liu","year":"2011","unstructured":"Liu, M. A. (2011). DNA vaccines: An historical perspective and view to the future. Immunological Reviews, 239(1), 62\u201384. https:\/\/doi.org\/10.1111\/j.1600-065x.2010.00980.x","journal-title":"Immunological Reviews"},{"issue":"1","key":"1595_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/1479-0556-1-2","volume":"1","author":"HS Garmory","year":"2003","unstructured":"Garmory, H. S., Brown, K. A., & Titball, R. W. (2003). DNA vaccines: Improving expression of antigens. Genetic Vaccines and Therapy, 1(1), Article 2. https:\/\/doi.org\/10.1186\/1479-0556-1-2","journal-title":"Genetic Vaccines and Therapy"},{"key":"1595_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1332939","volume":"15","author":"B Lu","year":"2024","unstructured":"Lu, B., Lim, J. M., Yu, B., Song, S., Neeli, P., Sobhani, N., K, P., Bonam, S. R., Kurapati, R., Zheng, J., & Chai, D. (2024). The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects. Frontiers in Immunology, 15, Article 1332939. https:\/\/doi.org\/10.3389\/fimmu.2024.1332939","journal-title":"Frontiers in Immunology"},{"key":"1595_CR76","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.14983553","author":"C Rejitha","year":"2025","unstructured":"Rejitha, C., Vidhyalakshmi, R., Saranya, P., Pratheeba, G., Khan, D., & Srinivasan, R. (2025). Biotechnology\u2019s impact on drug development and vaccine production. International Journal of Scientific Research and Technology. https:\/\/doi.org\/10.5281\/zenodo.14983553"},{"issue":"1","key":"1595_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","volume":"7","author":"T Travieso","year":"2022","unstructured":"Travieso, T., Li, J., Mahesh, S., Mello, J. D. F. R. E., & Blasi, M. (2022). The use of viral vectors in vaccine development. NPJ Vaccines, 7(1), 75. https:\/\/doi.org\/10.1038\/s41541-022-00503-y","journal-title":"NPJ Vaccines"},{"issue":"5","key":"1595_CR78","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/vaccines13050524","volume":"13","author":"J Tang","year":"2025","unstructured":"Tang, J., Amin, M. A., & Campian, J. L. (2025). Past, present, and future of viral vector vaccine platforms: A comprehensive review. Vaccines, 13(5), 524. https:\/\/doi.org\/10.3390\/vaccines13050524","journal-title":"Vaccines"},{"key":"1595_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1043109","volume":"14","author":"SK Verma","year":"2023","unstructured":"Verma, S. K., Mahajan, P., Singh, N. K., Gupta, A., Aggarwal, R., Rappuoli, R., & Johri, A. K. (2023). New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology, 14, Article 1043109. https:\/\/doi.org\/10.3389\/fimmu.2023.1043109","journal-title":"Frontiers in Immunology"},{"key":"1595_CR80","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.049601-0","author":"M Saxena","year":"2013","unstructured":"Saxena, M., Van, T. T. H., Baird, F. J., Coloe, P. J., & Smooker, P. M. (2013). Pre-existing immunity against vaccine vectors\u2013friend or foe? Microbiology. https:\/\/doi.org\/10.1099\/mic.0.049601-0","journal-title":"Microbiology"},{"issue":"2","key":"1595_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines14020144","volume":"14","author":"L Russo","year":"2026","unstructured":"Russo, L., Villani, L., Ieraci, R., & Ricciardi, W. (2026). Global health preparedness frameworks and recombinant vaccine platforms: A public health perspective on regulations and system readiness. Vaccines, 14(2), Article 144. https:\/\/doi.org\/10.3390\/vaccines14020144","journal-title":"Vaccines"},{"issue":"3","key":"1595_CR82","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","volume":"28","author":"K Bloom","year":"2021","unstructured":"Bloom, K., van den Berg, F., & Arbuthnot, P. (2021). Self-amplifying RNA vaccines for infectious diseases. Gene Therapy, 28(3), 117\u2013129. https:\/\/doi.org\/10.1038\/s41434-020-00204-y","journal-title":"Gene Therapy"},{"key":"1595_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2024.106998","volume":"224","author":"DB Olawade","year":"2024","unstructured":"Olawade, D. B., Teke, J., Fapohunda, O., Weerasinghe, K., Usman, S. O., Ige, A. O., & David-Olawade, A. C. (2024). Leveraging artificial intelligence in vaccine development: A narrative review. Journal of microbiological methods, 224, Article 106998. https:\/\/doi.org\/10.1016\/j.mimet.2024.106998","journal-title":"Journal of microbiological methods"},{"issue":"6","key":"1595_CR84","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s44222-023-00044-6","volume":"1","author":"L Eidenberger","year":"2023","unstructured":"Eidenberger, L., Kogelmann, B., & Steinkellner, H. (2023). Plant-based biopharmaceutical engineering. Nature Reviews Bioengineering, 1(6), 426\u2013439. https:\/\/doi.org\/10.1038\/s44222-023-00044-6","journal-title":"Nature Reviews Bioengineering"},{"issue":"2","key":"1595_CR85","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/vaccines14020173","volume":"14","author":"K Karczmarzyk","year":"2026","unstructured":"Karczmarzyk, K., & K\u0119sik-Brodacka, M. (2026). Challenges and prospects in the development of a universal SARS-CoV-2 vaccine. Vaccines, 14(2), 173. https:\/\/doi.org\/10.3390\/vaccines14020173","journal-title":"Vaccines"},{"key":"1595_CR86","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/B978-0-443-16013-4.00017-8","volume-title":"Biochemical and molecular pharmacology in drug discovery","author":"Y Sivamani","year":"2024","unstructured":"Sivamani, Y., Hegde, S., Bhat, A. R., Sajal, H., & Elayaperumal, S. (2024). Recombinant DNA technology and gene therapy. Biochemical and molecular pharmacology in drug discovery (pp. 353\u2013376). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-443-16013-4.00017-8"},{"key":"1595_CR87","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S302095","author":"TM Belete","year":"2021","unstructured":"Belete, T. M. (2021). The current status of gene therapy for the treatment of cancer. Biologics: Targets and Therapy. https:\/\/doi.org\/10.2147\/BTT.S302095","journal-title":"Biologics: Targets and Therapy"},{"issue":"5","key":"1595_CR88","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrg2985","volume":"12","author":"L Naldini","year":"2011","unstructured":"Naldini, L. (2011). Ex vivo gene transfer and correction for cell-based therapies. Nature Reviews Genetics, 12(5), 301\u2013315. https:\/\/doi.org\/10.1038\/nrg2985","journal-title":"Nature Reviews Genetics"},{"issue":"2","key":"1595_CR89","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.addr.2007.08.035","volume":"60","author":"MI Phillips","year":"2008","unstructured":"Phillips, M. I., & Tang, Y. L. (2008). Genetic modification of stem cells for transplantation. Advanced Drug Delivery Reviews, 60(2), 160\u2013172. https:\/\/doi.org\/10.1016\/j.addr.2007.08.035","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"1595_CR90","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11033-023-09096-8","volume":"51","author":"A Zafar","year":"2024","unstructured":"Zafar, A., Khan, M. J., Abu, J., & Naeem, A. (2024). Revolutionizing cancer care strategies: Immunotherapy, gene therapy, and molecular targeted therapy. Molecular Biology Reports, 51(1), 219. https:\/\/doi.org\/10.1007\/s11033-023-09096-8","journal-title":"Molecular Biology Reports"},{"issue":"6","key":"1595_CR91","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00439-006-0165-6","volume":"119","author":"KH Warrington Jr","year":"2006","unstructured":"Warrington, K. H., Jr., & Herzog, R. W. (2006). Treatment of human disease by adeno-associated viral gene transfer. Human genetics, 119(6), 571\u2013603. https:\/\/doi.org\/10.1007\/s00439-006-0165-6","journal-title":"Human genetics"},{"issue":"16","key":"1595_CR92","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1128\/jvi.74.16.7187-7195.2000","volume":"74","author":"RJ Miller","year":"2000","unstructured":"Miller, R. J., Cairns, J. S., Bridges, S., & Sarver, N. (2000). Human immunodeficiency virus and AIDS: Insights from animal lentiviruses. Journal of Virology, 74(16), 7187\u20137195. https:\/\/doi.org\/10.1128\/jvi.74.16.7187-7195.2000","journal-title":"Journal of Virology"},{"issue":"2","key":"1595_CR93","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/bjp.2008.349","volume":"157","author":"D Bouard","year":"2009","unstructured":"Bouard, D., Alazard\u2010Dany, N., & Cosset, F. L. (2009). Viral vectors: From virology to transgene expression. British Journal of Pharmacology, 157(2), 153\u2013165. https:\/\/doi.org\/10.1038\/bjp.2008.349","journal-title":"British Journal of Pharmacology"},{"key":"1595_CR94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/5584_2019_463","volume":"8","author":"B Arjmand","year":"2019","unstructured":"Arjmand, B., Larijani, B., Sheikh Hosseini, M., Payab, M., Gilany, K., Goodarzi, P., Parhizkar Roudsari, P., & Amanollahi, B. M. (2019). The horizon of gene therapy in modern medicine: Advances and challenges. Cell Biology and Translational Medicine, 8, 33\u201364. https:\/\/doi.org\/10.1007\/5584_2019_463","journal-title":"Cell Biology and Translational Medicine"},{"issue":"11","key":"1595_CR95","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s13346-023-01362-3","volume":"13","author":"DM Dogbey","year":"2023","unstructured":"Dogbey, D. M., Torres, V. E., Fajemisin, E., Mpondo, L., Ngwenya, T., Akinrinmade, O. A., Perriman, A. W., & Barth, S. (2023). Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. Drug Delivery and Translational Research, 13(11), 2719\u20132738. https:\/\/doi.org\/10.1007\/s13346-023-01362-3","journal-title":"Drug Delivery and Translational Research"},{"issue":"12","key":"1595_CR96","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/molecules25122866","volume":"25","author":"A Wahane","year":"2020","unstructured":"Wahane, A., Waghmode, A., Kapphahn, A., Dhuri, K., Gupta, A., & Bahal, R. (2020). Role of lipid-based and polymer-based non-viral vectors in nucleic acid delivery for next-generation gene therapy. Molecules, 25(12), 2866. https:\/\/doi.org\/10.3390\/molecules25122866","journal-title":"Molecules"},{"issue":"5","key":"1595_CR97","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s13346-023-01320-z","volume":"13","author":"F Sinclair","year":"2023","unstructured":"Sinclair, F., Begum, A. A., Dai, C. C., Toth, I., & Moyle, P. M. (2023). Recent advances in the delivery and applications of nonviral CRISPR\/Cas9 gene editing. Drug Delivery and Translational Research, 13(5), 1500\u20131519. https:\/\/doi.org\/10.1007\/s13346-023-01320-z","journal-title":"Drug Delivery and Translational Research"},{"issue":"4","key":"1595_CR98","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/jcp.30064","volume":"236","author":"B Zhang","year":"2021","unstructured":"Zhang, B. (2021). CRISPR\/Cas gene therapy. Journal of Cellular Physiology, 236(4), 2459\u20132481. https:\/\/doi.org\/10.1002\/jcp.30064","journal-title":"Journal of Cellular Physiology"},{"issue":"9","key":"1595_CR99","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00335-015-9565-z","volume":"26","author":"MV Wiles","year":"2015","unstructured":"Wiles, M. V., Qin, W., Cheng, A. W., & Wang, H. (2015). CRISPR\u2013Cas9-mediated genome editing and guide RNA design. Mammalian Genome, 26(9), 501\u2013510. https:\/\/doi.org\/10.1007\/s00335-015-9565-z","journal-title":"Mammalian Genome"},{"issue":"38","key":"1595_CR100","doi-asserted-by":"publisher","first-page":"2402630","DOI":"10.1002\/adfm.202402630","volume":"34","author":"X Yang","year":"2024","unstructured":"Yang, X., Bui, T. A., Mei, H., Aksoy, Y. A., Deng, F., Hutvagner, G., & Deng, W. (2024). Exploring the potential and challenges of CRISPR delivery and therapeutics for genetic disease treatment. Advanced Functional Materials, 34(38), 2402630. https:\/\/doi.org\/10.1002\/adfm.202402630","journal-title":"Advanced Functional Materials"},{"key":"1595_CR101","volume-title":"Diseases of the Retina and Vitreous","author":"HMV J\u00fanior","year":"2025","unstructured":"J\u00fanior, H. M. V., Ferraz Sallum, J. M., & Maia, A. (2025). Gene Therapy. In M. A. Ferreira (Ed.), Diseases of the Retina and Vitreous. Springer."},{"issue":"3","key":"1595_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030417","volume":"11","author":"T Aslesh","year":"2022","unstructured":"Aslesh, T., & Yokota, T. (2022). Restoring SMN expression: An overview of the therapeutic developments for the treatment of spinal muscular atrophy. Cells, 11(3), Article 417. https:\/\/doi.org\/10.3390\/cells11030417","journal-title":"Cells"},{"issue":"1","key":"1595_CR103","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41467-020-19507-0","volume":"11","author":"KA High","year":"2020","unstructured":"High, K. A. (2020). Turning genes into medicines\u2014what have we learned from gene therapy drug development in the past decade? Nature Communications, 11(1), 5821. https:\/\/doi.org\/10.1038\/s41467-020-19507-0","journal-title":"Nature Communications"},{"issue":"9","key":"1595_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202100040","volume":"4","author":"A Shahryari","year":"2021","unstructured":"Shahryari, A., Burtscher, I., Nazari, Z., & Lickert, H. (2021). Engineering gene therapy: Advances and barriers. Advanced Therapeutics, 4(9), Article 2100040. https:\/\/doi.org\/10.1002\/adtp.202100040","journal-title":"Advanced Therapeutics"},{"issue":"10","key":"1595_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101416","volume":"16","author":"AY Shchaslyvyi","year":"2023","unstructured":"Shchaslyvyi, A. Y., Antonenko, S. V., Tesliuk, M. G., & Telegeev, G. D. (2023). Current state of human gene therapy: Approved products and vectors. Pharmaceuticals, 16(10), Article 1416. https:\/\/doi.org\/10.3390\/ph16101416","journal-title":"Pharmaceuticals"},{"issue":"01","key":"1595_CR106","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0044-1785234","volume":"11","author":"ND Kolanu","year":"2024","unstructured":"Kolanu, N. D. (2024). CRISPR\u2013Cas9 gene editing: Curing genetic diseases by inherited epigenetic modifications. Global medical genetics, 11(01), 113\u2013122. https:\/\/doi.org\/10.1055\/s-0044-1785234","journal-title":"Global medical genetics"},{"issue":"1","key":"1595_CR107","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024). Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal transduction and targeted therapy, 9(1), 78. https:\/\/doi.org\/10.1038\/s41392-024-01780-w","journal-title":"Signal transduction and targeted therapy"},{"key":"1595_CR108","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128324084240828084904","author":"A Panday","year":"2024","unstructured":"Panday, A., Dixena, B., Jain, N., & Jain, A. K. (2024). Lipid-based non-viral vector: Promising approach for gene delivery. Current Pharmaceutical Design. https:\/\/doi.org\/10.2174\/0113816128324084240828084904","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"1595_CR109","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s12291-017-0688-8","volume":"32","author":"S Dwivedi","year":"2017","unstructured":"Dwivedi, S., Purohit, P., Misra, R., Pareek, P., Goel, A., Khattri, S., Pant, K. K., Misra, S., & Sharma, P. (2017). Diseases and molecular diagnostics: A step closer to precision medicine. Indian Journal of Clinical Biochemistry, 32(4), 374\u2013398. https:\/\/doi.org\/10.1007\/s12291-017-0688-8","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"1595_CR110","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-025-01390-z","author":"SM Hussain","year":"2025","unstructured":"Hussain, S. M., Sharif, A., Bashir, F., Ali, S., Javid, A., Hussain, A. I., Ghafoor, A., Alshehri, M. A., Naeem, A., Naeem, E., & Amjad, M. (2025). Polymerase Chain Reaction: A Toolbox for Molecular Discovery. Molecular Biotechnology. https:\/\/doi.org\/10.1007\/s12033-025-01390-z","journal-title":"Molecular Biotechnology"},{"issue":"7","key":"1595_CR111","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1128\/AEM.70.7.3795-3806.2004","volume":"70","author":"FH Sharkey","year":"2004","unstructured":"Sharkey, F. H., Banat, I. M., & Marchant, R. (2004). Detection and quantification of gene expression in environmental bacteriology. Applied and Environmental Microbiology, 70(7), 3795\u20133806. https:\/\/doi.org\/10.1128\/AEM.70.7.3795-3806.2004","journal-title":"Applied and Environmental Microbiology"},{"key":"1595_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/0470033363.ch1","author":"JL Serre","year":"2006","unstructured":"Serre, J. L. (2006). Techniques and tools in molecular biology used in genetic diagnoses. Diagnostic Techniques in Genetics. https:\/\/doi.org\/10.1002\/0470033363.ch1","journal-title":"Diagnostic Techniques in Genetics"},{"key":"1595_CR113","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-030-98554-7_2","volume-title":"Fundamentals and advances in medical biotechnology","author":"SA Bhat","year":"2022","unstructured":"Bhat, S. A., Sarwar, Z., Batool, A., & Bhat, S. A. (2022). Biotechnology in medicine: Fundamentals. Fundamentals and advances in medical biotechnology (pp. 21\u201365). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-98554-7_2"},{"key":"1595_CR114","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/B978-0-443-21980-1.00002-4","volume-title":"Genome analysis","author":"P Tiwari","year":"2026","unstructured":"Tiwari, P., Katiyar, H., Singh, R., & Shukla, A. (2026). Genome-based approaches for disease diagnosis. Genome analysis (pp. 543\u2013568). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-443-21980-1.00002-4"},{"key":"1595_CR115","volume-title":"Genetics and biotechnology: Principles, techniques, and applications","author":"MR Singh","year":"2025","unstructured":"Singh, M. R. (2025). Genetics and biotechnology: Principles, techniques, and applications. Academic Guru Publishing House."},{"issue":"10","key":"1595_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70482","volume":"15","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Wang, Q., Zhang, J., Li, B., Li, Y., Chen, Z., Guo, D., & Feng, S. (2025). CRISPR-driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges. Clinical and Translational Medicine, 15(10), Article e70482. https:\/\/doi.org\/10.1002\/ctm2.70482","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"1595_CR117","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1038\/s41467-025-58527-6","volume":"16","author":"GR Han","year":"2025","unstructured":"Han, G. R., Goncharov, A., Eryilmaz, M., Ye, S., Palanisamy, B., Ghosh, R., Lisi, F., Rogers, E., Guzman, D., Yigci, D., & Tasoglu, S. (2025). Machine learning in point-of-care testing: Innovations, challenges, and opportunities. Nature Communications, 16(1), 3165. https:\/\/doi.org\/10.1038\/s41467-025-58527-6","journal-title":"Nature Communications"},{"issue":"7","key":"1595_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ani13071223","volume":"13","author":"A Dominguez-Oliva","year":"2023","unstructured":"Dominguez-Oliva, A., Hern\u00e1ndez-\u00c1valos, I., Martinez-Burnes, J., Olmos-Hernandez, A., Verduzco-Mendoza, A., & Mota-Rojas, D. (2023). The importance of animal models in biomedical research: Current insights and applications. Animals, 13(7), Article 1223. https:\/\/doi.org\/10.3390\/ani13071223","journal-title":"Animals"},{"issue":"4025","key":"1595_CR119","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.175.4025.949","volume":"175","author":"T Friedmann","year":"1972","unstructured":"Friedmann, T., & Roblin, R. (1972). Gene therapy for human genetic disease? Proposals for genetic manipulation in humans raise difficult scientific and ethical problems. Science, 175(4025), 949\u2013955. https:\/\/doi.org\/10.1126\/science.175.4025.949","journal-title":"Science"},{"issue":"2","key":"1595_CR120","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11248-011-9537-3","volume":"21","author":"A Doyle","year":"2012","unstructured":"Doyle, A., McGarry, M. P., Lee, N. A., & Lee, J. J. (2012). The construction of transgenic and gene knockout\/knockin mouse models of human disease. Transgenic Research, 21(2), 327\u2013349. https:\/\/doi.org\/10.1007\/s11248-011-9537-3","journal-title":"Transgenic Research"},{"issue":"2\u20133","key":"1595_CR121","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0168-1656(02)00129-3","volume":"98","author":"LM Houdebine","year":"2002","unstructured":"Houdebine, L. M. (2002). The methods to generate transgenic animals and to control transgene expression. Journal of Biotechnology, 98(2\u20133), 145\u2013160. https:\/\/doi.org\/10.1016\/s0168-1656(02)00129-3","journal-title":"Journal of Biotechnology"},{"issue":"6","key":"1595_CR122","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1301\/nr2004.jun243-246","volume":"62","author":"CH Kos","year":"2004","unstructured":"Kos, C. H. (2004). Methods in nutrition science: Cre\/loxP system for generating tissue-specific knockout mouse models. Nutrition Reviews, 62(6), 243\u2013246. https:\/\/doi.org\/10.1301\/nr2004.jun243-246","journal-title":"Nutrition Reviews"},{"issue":"1","key":"1595_CR123","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bcp.2013.06.020","volume":"87","author":"BA Ruggeri","year":"2014","unstructured":"Ruggeri, B. A., Camp, F., & Miknyoczki, S. (2014). Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochemical Pharmacology, 87(1), 150\u2013161. https:\/\/doi.org\/10.1016\/j.bcp.2013.06.020","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"1595_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","volume":"12","author":"NC Walsh","year":"2017","unstructured":"Walsh, N. C., Kenney, L. L., Jangalwe, S., Aryee, K. E., Greiner, D. L., Brehm, M. A., & Shultz, L. D. (2017). Humanized mouse models of clinical disease. Annual Review of Pathology: Mechanisms of Disease, 12(1), 187\u2013215. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100332","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"11","key":"1595_CR125","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/v10110643","volume":"10","author":"F Lai","year":"2018","unstructured":"Lai, F., & Chen, Q. (2018). Humanized mouse models for the study of infection and pathogenesis of human viruses. Viruses, 10(11), 643. https:\/\/doi.org\/10.3390\/v10110643","journal-title":"Viruses"},{"issue":"11","key":"1595_CR126","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd.2016.175","volume":"15","author":"P Horvath","year":"2016","unstructured":"Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., \u00d6stling, P., Pieti\u00e4inen, V., Price, L. S., & Shorte, S. L. (2016). Screening out irrelevant cell-based models of disease. Nature Reviews Drug Discovery, 15(11), 751\u2013769. https:\/\/doi.org\/10.1038\/nrd.2016.175","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"1595_CR127","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40246-020-00276-2","volume":"14","author":"C De Masi","year":"2020","unstructured":"De Masi, C., Spitalieri, P., Murdocca, M., Novelli, G., & Sangiuolo, F. (2020). Application of CRISPR\/Cas9 to human-induced pluripotent stem cells: From gene editing to drug discovery. Human Genomics, 14(1), 25. https:\/\/doi.org\/10.1186\/s40246-020-00276-2","journal-title":"Human Genomics"},{"issue":"1","key":"1595_CR128","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40779-023-00447-x","volume":"10","author":"ZH Li","year":"2023","unstructured":"Li, Z. H., Wang, J., Xu, J. P., Wang, J., & Yang, X. (2023). Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research. Military Medical Research, 10(1), 12. https:\/\/doi.org\/10.1186\/s40779-023-00447-x","journal-title":"Military Medical Research"},{"issue":"7","key":"1595_CR129","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s44222-024-00207-z","volume":"2","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Landau, S., Okhovatian, S., Liu, C., Lu, R. X., Lai, B. F., Wu, Q., Kieda, J., Cheung, K., Rajasekar, S., & Jozani, K. (2024). Integrating organoids and organ-on-a-chip devices. Nature Reviews Bioengineering, 2(7), 588\u2013608. https:\/\/doi.org\/10.1038\/s44222-024-00207-z","journal-title":"Nature Reviews Bioengineering"},{"issue":"2","key":"1595_CR130","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v3i2.184","volume":"3","author":"AN Ansori","year":"2023","unstructured":"Ansori, A. N., Antonius, Y., Susilo, R. J., Hayaza, S., Kharisma, V. D., Parikesit, A. A., Zainul, R., Jakhmola, V., Saklani, T., & Rebezov, M. (2023). Application of CRISPR-Cas9 genome editing technology in various fields: A review. Narra J, 3(2), Article e184. https:\/\/doi.org\/10.52225\/narra.v3i2.184","journal-title":"Narra J"},{"key":"1595_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101438","volume":"30","author":"Y Shao","year":"2025","unstructured":"Shao, Y., Wang, J., Jin, A., Jiang, S., Lei, L., & Liu, L. (2025). Biomaterial-assisted organoid technology for disease modeling and drug screening. Materials Today Bio, 30, Article 101438. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101438","journal-title":"Materials Today Bio"},{"issue":"1","key":"1595_CR132","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-09066-0","volume":"51","author":"AV Bruter","year":"2024","unstructured":"Bruter, A. V., Varlamova, E. A., Okulova, Y. D., Tatarskiy, V. V., Silaeva, Y. Y., & Filatov, M. A. (2024). Genetically modified mice as a tool for the study of human diseases. Molecular Biology Reports, 51(1), Article 135. https:\/\/doi.org\/10.1007\/s11033-023-09066-0","journal-title":"Molecular Biology Reports"},{"key":"1595_CR133","first-page":"1","volume":"82","author":"A Neinaber","year":"2019","unstructured":"Neinaber, A. (2019). Meaningful knowledge: Law and ethics in post-genomic gene therapy research. THRHR, 82, 1.","journal-title":"THRHR"},{"key":"1595_CR134","doi-asserted-by":"publisher","DOI":"10.1128\/9781555815899.ch28","author":"TA Kost","year":"2006","unstructured":"Kost, T. A., Patrick, C. J., & Mickelson, C. A. (2006). Biosafety and viral gene transfer vectors. Biological safety: Principles and practices. https:\/\/doi.org\/10.1128\/9781555815899.ch28","journal-title":"Biological safety: Principles and practices"},{"key":"1595_CR135","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1201\/9781003178361-20","volume-title":"Pharmaceutical biotechnology","author":"CM Crnkovic","year":"2021","unstructured":"Crnkovic, C. M., Caricati, C. P., de Souza Oliveira, R. P., & Stephano, M. A. (2021). Biosafety applied in pharmaceutical and biotechnological processes. Pharmaceutical biotechnology (pp. 313\u2013324). CRC Press."},{"key":"1595_CR136","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1163\/9789004391192_020","volume-title":"Animal experimentation: Working towards a paradigm change","author":"J Bailey","year":"2019","unstructured":"Bailey, J. (2019). Genetic modification of animals: Scientific and ethical issues. Animal experimentation: Working towards a paradigm change (pp. 443\u2013479). Brill."},{"issue":"1","key":"1595_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-020-00524-z","volume":"21","author":"KR Jongsma","year":"2020","unstructured":"Jongsma, K. R., & Bredenoord, A. L. (2020). Ethics parallel research: An approach for (early) ethical guidance of biomedical innovation. BMC Medical Ethics, 21(1), Article 81. https:\/\/doi.org\/10.1186\/s12910-020-00524-z","journal-title":"BMC Medical Ethics"},{"issue":"22","key":"1595_CR138","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1111\/bph.14485","volume":"175","author":"H Langhof","year":"2018","unstructured":"Langhof, H., Chin, W. W. L., Wieschowski, S., Federico, C., Kimmelman, J., & Strech, D. (2018). Preclinical efficacy in therapeutic area guidelines from the US Food and Drug Administration and the European Medicines Agency: A cross-sectional study. British Journal of Pharmacology, 175(22), 4229\u20134238. https:\/\/doi.org\/10.1111\/bph.14485","journal-title":"British Journal of Pharmacology"},{"key":"1595_CR139","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1201\/9781003343981-8","volume-title":"Artificial intelligence in pharmaceutical sciences","author":"N Kirubakaran","year":"2023","unstructured":"Kirubakaran, N., Rani, K. R. V., Srinivasan, U. M., Mohandoss, K., Rajamani, Y. S., Alharbi, H. F., & Anbazhagan, S. (2023). Pharmaceutical drugs, biologics, gene therapies, and medical device regulation. Artificial intelligence in pharmaceutical sciences (pp. 117\u2013129). CRC Press."},{"key":"1595_CR140","first-page":"267","volume-title":"Hec Forum","author":"L Wiley","year":"2025","unstructured":"Wiley, L., Cheek, M., LaFar, E., Ma, X., Sekowski, J., Tanguturi, N., & Iltis, A. (2025). The ethics of human embryo editing via CRISPR-Cas9 technology: A systematic review of ethical arguments, reasons, and concerns. Hec Forum (pp. 267\u2013303). Springer."},{"key":"1595_CR141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.37983\/IJDM.2025.7105","volume":"7","author":"P Kollabathula","year":"2025","unstructured":"Kollabathula, P., Katru, S., Tumarada, P., Ravuri, S., Zainab, A., & Velagala, S. K. (2025). Harnessing recombinant DNA technology for modern innovations: A review. International Journal of Dental Materials, 7, 27\u201331. https:\/\/doi.org\/10.37983\/IJDM.2025.7105","journal-title":"International Journal of Dental Materials"},{"issue":"7991","key":"1595_CR142","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/d41586-023-03797-7","volume":"624","author":"H Ledford","year":"2023","unstructured":"Ledford, H. (2023). CRISPR 2.0: A new wave of gene editors heads for clinical trials. Nature, 624(7991), 234\u2013235. https:\/\/doi.org\/10.1038\/d41586-023-03797-7","journal-title":"Nature"},{"issue":"6376","key":"1595_CR143","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1067","volume":"359","author":"T Kitada","year":"2018","unstructured":"Kitada, T., DiAndreth, B., Teague, B., & Weiss, R. (2018). Programming gene and engineered-cell therapies with synthetic biology. Science, 359(6376), Article eaad1067. https:\/\/doi.org\/10.1126\/science.aad1067","journal-title":"Science"},{"key":"1595_CR144","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-981-97-1148-2_","volume-title":"Concepts in pharmaceutical biotechnology and drug development","author":"G Dey","year":"2024","unstructured":"Dey, G., Rakshit, P., Ghosh, N., Banerjee, S., Banerjee, S., & De, S. (2024). Application of biotechnology in pharmaceutical manufacturing control. Concepts in pharmaceutical biotechnology and drug development (pp. 31\u201342). Springer Nature Singapore. https:\/\/doi.org\/10.1007\/978-981-97-1148-2_"},{"issue":"2","key":"1595_CR145","doi-asserted-by":"publisher","first-page":"30","DOI":"10.57238\/tpb.2024.153196.1020","volume":"2","author":"W Mohammad","year":"2024","unstructured":"Mohammad, W., & Al Sayeh, A. (2024). mRNA vaccines beyond COVID-19: Emerging therapeutic frontiers. Trends in Pharmaceutical Biotechnology, 2(2), 30\u201337.","journal-title":"Trends in Pharmaceutical Biotechnology"},{"issue":"6","key":"1595_CR146","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/vaccines13060588","volume":"13","author":"M Eslami","year":"2025","unstructured":"Eslami, M., Fadaee Dowlat, B., Yaghmayee, S., Habibian, A., Keshavarzi, S., Oksenych, V., & Naderian, R. (2025). Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity. Vaccines, 13(6), 588. https:\/\/doi.org\/10.3390\/vaccines13060588","journal-title":"Vaccines"},{"issue":"7794","key":"1595_CR147","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. (2020). The promise and challenge of therapeutic genome editing. Nature, 578(7794), 229\u2013236. https:\/\/doi.org\/10.1038\/s41586-020-1978-5","journal-title":"Nature"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-026-01595-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:04:12Z","timestamp":1783303452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-026-01595-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":147,"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1007\/s12033-026-01595-w","relation":{"references":[{"id-type":"doi","id":"10.5281\/zenodo.14983553","asserted-by":"subject"}]},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,5]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest and adheres to copyright norms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}